Clinical Trial Update: 2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing paclitaxel plus bevacizumab to capecitabine plus bevacizumab in metastatic breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Central European Cooperative Oncology Group | Conditions: Metastatic Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-12-30